Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
DescriptionVenture Capital for Healthcare Future



Rowayton, USA
105 Rowayton Avenue
Rowayton, CT, 06853


General Partner & Co-Founder
General Partner
General Partner
Partner, CFO
Partner Emeritus
Executive Partner
Clinical Partner
Clinical Partner


Foundation Medical Partners

Investing in Innovation, Building Life Science Companies

Foundation Medical Partners is a leading national, independent, healthcare venture capital investment firm. Foundation was formed in 2001 with the vision of bringing together cutting edge life science expertise with deep company-building experience. Foundation specializes in early stage investments in the medical device, biopharmaceutical, and predictive medicine technology sectors. Foundation is an active venture investor, providing leadership, support, and strategic resources at every stage in a company’s development.

Proven Success, Top Tier Performance

Foundation Medical Partners was an early, active venture investor in such now-public companies as AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT), Combinatorx (NASDAQ: CRXX), and Northstar Neuroscience (NASDAQ: NSTR), as well as a portfolio of other market-leading privately held firms. Foundation actively manages over $200 million in venture capital, with a current market capitalization of its healthcare investments totaling over $1.6 billion.

Wide Network, Unparalleled Strategic Resources

Foundation Medical Partners draws on a wide network of specialized resources within the healthcare industry and academic medical environment. Contributing to Foundation’s clinical expertise is its unique strategic limited partnership affiliation with Cleveland Clinic. This partnership is a powerful asset for Foundation and its portfolio companies.

Foundation’s special relationship with Cleveland Clinic allows the firm and its portfolio companies to directly access and work closely with physicians, surgeons, and scientists throughout Cleveland Clinic. The enormous intellectual and experiential capacity made available to Foundation and its portfolio companies through this relationship is unparalleled in healthcare venture capital. Foundation leverages this to full advantage in deal sourcing and due diligence, as well as in key company building activities, such as scientific advisory board support, development partnerships, beta site testing, clinical trial leadership, or key reference customer development.

Pioneer in Medicine, World-Class Partner

Foundation Medical Partners’ strategic limited partner, Cleveland Clinic, is one of the most widely recognized and innovative medical centers in the world. Cleveland Clinic is a private, non-profit group practice that includes a 954-bed hospital, outpatient services, a research institute, and an education foundation. As a world-class academic medical center that is a designated national referral center and international health resource, Cleveland Clinic provides the full range of medical services. Cleveland Clinic was ranked in 2008 as one of the top five best hospitals in the United States by U.S. News & World Report’s guide to America’s Best Hospitals. The Cleveland Clinic Heart Center continues its reign as the best medical center for cardiac care, having received this number one ranking in the guide every year since 1994. In addition, ten of its specialties were listed among the Top 10 in the United States and all of the Clinic’s specialties placed in the nation’s top 25.

While Foundation Medical Partners enjoys all of the benefits of this strategic partnership with Cleveland Clinic, the firm maintains complete independence from the structural and governance perspectives and operates with the traditional independent venture capital model.

Recent Milestones


Company Date Round Size Participants
Predilytics 9/2013Venture Round$4.5M2
SetPoint Medical 8/2013Series A$30.6M7
Marinus Pharmaceuticals 1/2013Series C$21M4
IlluminOss Medical 9/2012Series C$28M9
EndoGastric Solutions 6/2012Series F$13M7
EndoGastric Solutions 4/2012Venture Round$2.11M7
Direct Flow Medical 4/2012Venture Round$284k9
EndoGastric Solutions 3/2012Series G$10.9M4
BridgePoint Medical 3/2011Series C$9.1M3
Spine Wave 2/2011Series E$17.5M5
Semprus BioSciences 12/2010Series B$18M5
NeuroVista 8/2010Venture Round$16.5M4
EndoGastric Solutions 1/2010Series E$21.5M6
Vertos Medical 1/2010Series D$15.5M5
CircuLite 1/2010Series C$32.5M4
Coapt Systems 12/2009Debt$3.72M8
EndoGastric Solutions 10/2009Venture Round$9.5M6
CardioMEMS 10/2009Series F$22.1M10
Direct Flow Medical 10/2009Series C$40M7
EndoGastric Solutions 6/2009Venture Round$3.75M5
Visiogen 5/2009Series D$40M7
Marinus Pharmaceuticals 5/2009Series B$20M4
NeuroVista 5/2007Series B$33.8M5
Coapt Systems 3/2007Series E$22.6M7
BridgePoint Medical 1/2007Series B$10M3
EndoGastric Solutions 9/2004Series B$12M3



  1. Predilytics secures funding and expands board ( [edit]
  2. SEC ( [edit]
  3. Marinus Pharmaceuticals Raises $21M Funding in Series C Financing ( [edit]
  4. IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair ( [edit]
  5. EndoGastric Solutions Raises $13M in Series F Funding ( [edit]
  6. VC Funding: Q2 2012 source [edit]
  7. VC Funding: Q2 2012 source [edit]
  8. Endogastric Solutions Raises US$10.9 Million In Series G Financing ( [edit]
  9. BridgePoint Medical, Inc.: Series C $9.1M ( [edit]
  10. Spine Wave rounds up $17.5M financing ( [edit]
  12. NeuroVista Raises $16.5 Million in Equity Financing ( [edit]
  13. EndoGastric Solutions, Inc.: Series E $21.5M ( [edit]
  14. Vertos Medical, Inc.: Series D $15.5M ( [edit]
  15. CircuLite Completes $32.5M Series C Financing ( [edit]
  16. Coapt Systems takes $3.7M for facial rejuvenation ( [edit]
  17. Xconomy Seattle ( [edit]
  18. CardioMEMS, Inc.: Series F $22.1M ( [edit]
  19. Direct Flow Medical takes $40M for heart valve treatments ( [edit]
  20. Xconomy Seattle ( [edit]
  21. Visiogen, Inc.: Series D $40M ( [edit]
  22. Marinus Pharmaceuticals, Inc.: Series B $20M ( [edit]
  23. NeuroVista raises $33.8M in venture capital ( [edit]
  24. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more ( [edit]
  25. BridgePoint Medical, Inc. Raises $10 Million in Series B Financing ( [edit]
  26. Xconomy Seattle ( [edit]
Edit This Page
Last Edited 2/10/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy